BlackRock’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $33.6M | Sell |
|
|||||
|
2025
Q2 | $14.9M | Sell |
|
|||||
|
2025
Q1 | $14.7M | Sell |
|
|||||
|
2024
Q4 | $27.4M | Buy |
|
|||||
|
2024
Q3 | $52.6M | Sell |
|
|||||
|
2024
Q2 | $103M | Buy |
|
|||||
|
2024
Q1 | $137M | Buy |
|
|||||
|
2023
Q4 | $70.2M | Buy |
|
|||||
|
2023
Q3 | $39.8M | Buy |
|
|||||
|
2023
Q2 | $52.7M | Buy |
|
|||||
|
2023
Q1 | $43.8M | Buy |
|
|||||
|
2022
Q4 | $55.7M | Buy |
|
|||||
|
2022
Q3 | $17.9M | Buy |
|
|||||
|
2022
Q2 | $15.2M | Buy |
|
|||||
|
2022
Q1 | $32.2M | Buy |
|
|||||
|
2021
Q4 | $45.8M | Buy |
|
|||||
|
2021
Q3 | $38.8M | Buy |
|
|||||
|
2021
Q2 | $17.6M | Buy |
|
|||||
|
2021
Q1 | $23.7M | Buy |
|
|||||
|
2020
Q4 | $246K | Buy |
|